BenevolentAI 2024 Innovation Presentation

BenevolentAI presentation showcasing the company's pioneering role in AI-driven drug discovery and development. The deck highlights industry firsts including the first AI-designed drug target licensed to pharma, first clinical trials of AI-discovered repurposed drugs, and first FDA approvals of AI-enabled therapeutics.